Sunday 27 September 2020

SMIC - Leading Chip maker in China

  • The US government is seeking to escalate its tech war against China by considering adding China's leading chipmaker SMIC to a trade blacklist, threatening to further disrupt a massive $300 billion-worth annual chip trade between China and other countries, including the US, whose companies sold about $70 billion worth of chips to China in 2019 alone.
  • UMC to be a major beneficiary from the US’ potential ban
  • UMC ranked as the world’s fourth-biggest foundry last quarter, with revenue of US$1.44 billion, while SMIC had US$941 million in revenue, according to the statistics compiled by market researcher TrendForce Corp
  • Both companies offer 14 nanometers as their most advanced process technology, but SMIC generates a large part of its revenue from less advanced chips
  • Novatek Microelectronics Corp , which supplies chips that control flat-panel displays, would be another beneficiary and could see a rebound in its share price, as the US ban would make it difficult for SMIC to tap into the driver IC market
  • UMC, Vanguard International Semiconductor Corp and GlobalFoundries Inc are likely to receive orders transferred from SMIC if the Trump administration further tightened its grip on SMIC and other Chinese semiconductor companies
  • Since UMC and Vanguard are running their 8-inch fabs at almost full capacity, they could see an uptick in chip prices amid supply constraints, while UMC and TSMC could see an increase in demand for less advanced chips made by their 12-inch fabs,

Value added product from Papaya - so many benefits !

Steroids - Database - technology sourcing, project details, market scenario

Reforms !


 

Thursday 10 September 2020

PVC Resin imports into India


 

Bearing Fruit ?


 

True or False ?


 

Plasma therapy didn’t help COVID­19 patients: ICMR


 

How much RISK are you taking?


 

Income dips by ₹174 cr. at Shirdi Saibaba temple


 

Silk Imports from China


 

Speciality chemicals firms eye fundraise


 

Tile makers bet on exports amid poor domestic demand

Dr Reddy’s launches remdesivir for covid-19 treatment in India

Recovery for India

Vaccines Business

New Jobs !

AstraZeneca - when to re-start?

AstraZeneca